Compared to Estimates, HCA (HCA) Q4 Earnings: A Look at Key Metrics

Core Insights - HCA Healthcare reported $18.29 billion in revenue for Q4 2024, a year-over-year increase of 5.7% [1] - The EPS for the same period was $6.22, up from $5.90 a year ago, exceeding the consensus estimate of $5.97 by 4.19% [1] Financial Performance - Revenue surpassed the Zacks Consensus Estimate of $18.09 billion, resulting in a surprise of +1.07% [1] - HCA's shares returned +7.5% over the past month, outperforming the Zacks S&P 500 composite's +2.5% change [3] Key Metrics - Revenue per Equivalent Admission was $18,146, exceeding the five-analyst average estimate of $18,036.69 [4] - Equivalent Admissions reached 1.01 billion, surpassing the five-analyst average estimate of 997.59 million [4] - Admissions totaled 559.17 million, slightly below the average estimate of 561.41 million [4] - Equivalent Patient Days were 4.85 million, close to the average estimate of 4.89 million [4] - Average Length of Stay remained at 5 days, matching the two-analyst average estimate [4] - The number of hospitals increased to 190, above the two-analyst average estimate of 187 [4] - Inpatient Revenue per Admission was $19,737, exceeding the average estimate of $19,608.16 [4] - Licensed Beds at the end of the period were 49,985, slightly above the two-analyst average estimate of 49,819 [4] - Patient Days were recorded at 2,691.71, below the average estimate of 2,714.32 [4] - The number of freestanding outpatient surgery centers was 124, slightly below the average estimate of 125 [4]